Literature DB >> 11687869

Ulcerative colitis and sarcoidosis.

N Nilubol1, P J Taub, M Venturero, S Lichtiger, J J Bauer.   

Abstract

A 38-year-old woman with ulcerative colitis subsequently developed sarcoidosis. After ten years of recurrent episodes of colitis, she had presented with respiratory symptoms. The diagnosis of sarcoidosis was confirmed by mediastinal lymph node biopsy. Her respiratory symptoms gradually resolved without any specific treatment. Within the remission period of sarcoidosis, she underwent uneventful subtotal colectomy due to refractory colitis. Alterations in immune function and genetic susceptibility have been suggested to be present in both ulcerative colitis and sarcoidosis. However, the occurrence of both in the same patient has been rare. This is only the nineteenth case reported in the literature.

Entities:  

Mesh:

Year:  2001        PMID: 11687869

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  4 in total

1.  Juvenile sarcoidosis presenting as Crohn's disease.

Authors:  Jürgen Brunner; Consolato Sergi; Thomas Müller; Ingmar Gassner; Friederike Prüfer; Lothar Bernd Zimmerhackl
Journal:  Eur J Pediatr       Date:  2006-03-18       Impact factor: 3.183

2.  Ulcerative colitis combined with acute interstitial lung disease and airway disease: A case report and literature review.

Authors:  Lisheng Xu; Wei Xiao; Dedong Ma; Shengyu Zhou; Qinghui Zhang
Journal:  Exp Ther Med       Date:  2014-08-11       Impact factor: 2.447

3.  Sarcoidosis is associated with lower risks of penetrating disease and colectomy in hospitalized patients with inflammatory bowel disease.

Authors:  Yi Jiang; Daniel S Rim; Brandon Rodgers; Sushil Ahlawat
Journal:  JGH Open       Date:  2020-10-05

4.  Sarcoidosis development during ulcerative colitis remission in a patient with a susceptible human leukocyte antigen serotype.

Authors:  Toshiyuki Sumi; Gen Yamada; Takafumi Yorozuya; Yusuke Tanaka; Yasumasa Tanaka; Yuji Sakuma; Hiroki Takahashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-03-31       Impact factor: 0.670

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.